ARCHIVES

Targeting One Specific Protein Can Double PFS; Triple Overall Survival

This article is from The Cancer Letter archive.

Vol. 34 No. 5 | May 27, 2011

Download PDF Visit The Full Archive

Related Articles

Turmoil in Texas: DePinho Recommended AVEO Stock on CNBC Six Days After FDA Said New Trial Was Needed

May 10, 2013

Avon Awards $50 Million To NCI And Three Centers.

October 12, 2001

“Our Job Is to Be The One Agency That Speaks To Cancer”

October 28, 1994

DCT Board Approves Concepts Of Five Contract Recompetitions

October 14, 1983

NeoPharm To Begin Phase III Trial For Glioblastoma

December 26, 2003

In Brief: Cancer Act Renewal Hearings Completed ; Administration Stays With Objections To More Centers, Specific Budget Figures

February 22, 1974